Health Care Sector
895 health care stocks ranked by market capitalization, page 14 of 18. Updated October 11, 2026.
Today
+1.52%Health Care stocks ranked 651–700
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 651 | EQ | Equillium Inc. | 1.41 | -2.08% | 522.00K | $89.41M |
| 652 | ICCC | ImmuCell Corporation | 9.80 | +0.51% | 1.86K | $89.01M |
| 653 | ISPR | Ispire Technology Inc. | 1.52 | +4.11% | 21.59K | $87.79M |
| 654 | ECOR | electroCore Inc. | 9.66 | +1.58% | 44.56K | $87.09M |
| 655 | NRXS | Neuraxis Inc. | 6.93 | +2.36% | 56.73K | $87.03M |
| 656 | FTLF | FitLife Brands Inc. | 9.21 | +5.86% | 14.55K | $86.49M |
| 657 | PMN | ProMIS Neurosciences Inc. | 9.61 | +5.03% | 18.85K | $86.18M |
| 658 | CRDF | Cardiff Oncology Inc. | 1.08 | +1.89% | 298.12K | $84.02M |
| 659 | RFL | Rafael Holdings Inc. Class B | 1.60 | +8.11% | 93.91K | $83.20M |
| 660 | TELO | Telomir Pharmaceuticals Inc. | 1.12 | -2.61% | 64.65K | $82.45M |
| 661 | ZYBT | Zhengye Biotechnology Holding Limited Class A | 1.73 | +50.45% | 30.60M | $81.99M |
| 662 | ACRV | Acrivon Therapeutics Inc. | 1.91 | +2.14% | 192.04K | $81.85M |
| 663 | NTRB | Nutriband Inc. | 6.65 | +9.92% | 45.14K | $80.84M |
| 664 | SERA | Sera Prognostics Inc. Class A | 2.04 | +0.99% | 6.30K | $80.48M |
| 665 | NTHI | NeOnc Technologies Holdings Inc. | 2.78 | +9.88% | 165.85K | $80.08M |
| 666 | SDEV | Stablecoin Development Corporation | 1.54 | -22.61% | 15.18M | $79.70M |
| 667 | LUNG | Pulmonx Corporation | 1.84 | +1.66% | 204.44K | $79.02M |
| 668 | SKYA | SkyAI Inc. | 1.82 | +7.69% | 268.41K | $78.71M |
| 669 | PTHS | Pelthos Therapeutics Inc. | 20.50 | 0.00% | 45.02K | $78.48M |
| 670 | LNSR | LENSAR Inc. | 6.37 | -1.24% | 15.33K | $78.26M |
| 671 | INCR | Intercure Ltd. | 5.17 | +2.99% | 484 | $77.57M |
| 672 | OM | Outset Medical Inc. | 4.05 | -0.98% | 73.22K | $76.13M |
| 673 | OSTX | OS Therapies Incorporated | 1.62 | 0.00% | 418.34K | $75.82M |
| 674 | LFVN | Lifevantage Corporation | 6.00 | +0.17% | 23.15K | $75.54M |
| 675 | MAIA | MAIA Biotechnology Inc. | 1.22 | +6.09% | 374.63K | $75.33M |
| 676 | MNOV | Medicinova Inc | 1.52 | -1.30% | 69.89K | $74.82M |
| 677 | OKYO | OKYO Pharma Limited | 1.42 | +2.16% | 115.50K | $74.52M |
| 678 | NMAD | Nomad Power Solutions Inc. | 4.53 | +6.09% | 165.49K | $72.94M |
| 679 | MBOT | Microbot Medical Inc. | 1.07 | 0.00% | 637.70K | $71.87M |
| 680 | GANX | Gain Therapeutics Inc. | 1.64 | +1.55% | 328.69K | $71.58M |
| 681 | FBIO | Fortress Biotech Inc. | 2.14 | +2.15% | 186.21K | $71.20M |
| 682 | CING | Cingulate Inc. | 4.89 | +0.20% | 27.84K | $71.11M |
| 683 | VRCA | Verrica Pharmaceuticals Inc. | 4.11 | -1.67% | 46.55K | $70.60M |
| 684 | HYFT | MindWalk Holdings Corp. | 1.50 | +4.55% | 238.91K | $70.43M |
| 685 | TENX | Tenax Therapeutics Inc. | 1.87 | +0.54% | 2.35M | $69.98M |
| 686 | SPRO | Spero Therapeutics Inc. | 1.20 | +5.26% | 439.18K | $69.88M |
| 687 | XBIT | XBiotech Inc. | 2.29 | +4.09% | 88.03K | $69.82M |
| 688 | GRML | Greenland Mines Ltd. | 5.17 | -12.07% | 3.68M | $69.00M |
| 689 | CSBR | Champions Oncology Inc. | 4.84 | -2.81% | 1.87K | $67.37M |
| 690 | ESYN | EnerSyn Global Inc. | 2.16 | +2.13% | 20.79K | $64.21M |
| 691 | PLRX | Pliant Therapeutics Inc. | 1.02 | +2.00% | 288.53K | $63.16M |
| 692 | APLM | Apollomics Inc. Class A | 21.50 | -0.92% | 8.79K | $62.67M |
| 693 | DXR | Daxor Corporation | 10.41 | -0.48% | 7.46K | $60.78M |
| 694 | APT | Alpha Pro Tech Ltd. | 5.84 | -2.67% | 53.75K | $59.60M |
| 695 | XLO | Xilio Therapeutics Inc. | 9.05 | +0.44% | 5.53K | $59.55M |
| 696 | GUTS | Fractyl Health Inc. | 4.42 | +4.49% | 198.30K | $58.63M |
| 697 | BOLD | Boundless Bio Inc. | 2.53 | -1.94% | 166.79K | $58.47M |
| 698 | RNXT | RenovoRx Inc. | 1.28 | -3.76% | 798.79K | $57.77M |
| 699 | GOSS | Gossamer Bio Inc. | 9.31 | -5.77% | 291.00K | $56.94M |
| 700 | DRIO | DarioHealth Corp. | 5.80 | +4.69% | 2.62K | $56.84M |
Prices as of Oct 11, 10:40 PM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer